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Introduction {#sec1}
============

Mathematical modeling is a powerful tool to describe complex biological processes, formalize interactions between components, analyze temporal dynamics, and predict the effects of perturbations ([@bib28]). Modeling has been used to describe liver functions and dynamics in mammals under normal and pathological conditions ([@bib4], [@bib18], [@bib25], [@bib40]).

The liver is the main detoxifying organ of the body, which can be injured by ingested toxins and infections. In response to these insults, hepatocytes can proliferate ([@bib36]), and regeneration of the liver has evolved as a protective mechanism ([@bib49]). Indeed, the mammalian liver displays a high regeneration potential ([@bib15], [@bib36], [@bib49]), and this phenomenon was described in rats a long time ago through the two-thirds partial hepatectomy model ([@bib23]).

After partial hepatectomy, the remaining lobes grow and liver mass is restored in approximately 1 week in rodents ([@bib12]). The regeneration mechanism is largely attributed to the re-entry of the hepatocytes into the cell cycle and their proliferation ([@bib15], [@bib35]), which peaks 48 hr after resection in mice ([@bib38]). Cooperative signals induced by growth factors (such as hepatocyte, transforming, and epidermal growth factors, insulin, and glucagons) and cytokines (such as tumor necrosis factor and interleukin 6) are thought to be responsible for hepatocyte re-entry into the cell cycle, DNA replication, proliferation, and consequent liver mass regeneration ([@bib5]).

However, there are still many unresolved key aspects in this process. The cell volume of hepatocytes enlarges ([@bib19], [@bib38]), and there is a massive increase of hematopoietic stem cells (HSCs) in the peripheral blood and in the liver itself ([@bib8], [@bib17], [@bib32]), whose role is not clear. In addition, there is some diverging evidence indicating that bone marrow (BM)-derived cells can either transdifferentiate in vivo in the mouse liver ([@bib1], [@bib31]) or can fuse with hepatocytes in fumarylacetoacetate hydrolase (Fah)-deficient mice ([@bib50], [@bib51]).

Here, using modeling and experimental approaches, we prove a crucial role of bone marrow cells (BMCs) and of BM-hepatocyte hybrids in the dynamics and efficiency of mouse liver regeneration upon 30% and 70% partial hepatectomy. A mathematical model, fitted on experimental data, unveils the critical role of BMC recruitment and hybrid formation in enhancing proliferation and, ultimately, liver regeneration.

Results {#sec2}
=======

Mathematical Model Recapitulates the Dynamics of Mouse Liver Regeneration after Hepatectomy {#sec2.1}
-------------------------------------------------------------------------------------------

In earlier work, a mathematical model for white rat liver regeneration upon partial hepatectomy was proposed ([@bib18]), which incorporates the main phenomenology and underlying signaling. Similarly, the mathematical formalism of our delay differential equations (DDEs) captures the rate of change in cell numbers, considering the three populations previously suggested to contribute to liver regeneration ([@bib15]): quiescent (Q), primed to replicate (P), and replicating (R) cells ([Figure 1](#fig1){ref-type="fig"}A). Coupled to cellular equations ([Figure S1](#mmc1){ref-type="supplementary-material"}A), molecular equations describe immediate-early genes, cytokines, and growth factors that, activated upon liver resection, determine the transition among cell states ([Figure S1](#mmc1){ref-type="supplementary-material"}B; [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). The premise of our model is the focus on regeneration dynamics rather than on cellular species. Thus, we adapted the phenomenological parameters in the cellular equations, whereas the molecular equations and the related parameters were kept as intact as possible ([Table S1](#mmc2){ref-type="supplementary-material"}). Notably, the same approach has been successfully used in adapting the rat model ([@bib18]) to reproduce data from humans ([@bib40]) because the biochemistry of liver regeneration is probably similar in different mammals.

To adapt the rat model, we noticed that, while in the rat, hepatocyte proliferation starts soon after hepatectomy ([@bib18]), in mice, the proliferation is delayed and peaks at 48 hr ([@bib38], [@bib52]). As expected, 24 hr upon 70% resection in wild-type mice, liver cells did not proliferate ([Figure S1](#mmc1){ref-type="supplementary-material"}C) ([@bib44]). We evaluated liver mass regeneration 7 days after resection ([Figure 1](#fig1){ref-type="fig"}B, no AMD3100) because this is a standard time range to analyze regeneration ([@bib54]). Interestingly, we observed a small but significant (p \< 0.0001 between post-hepatectomy and day 1) increase in liver mass at day 1 ([Figure 1](#fig1){ref-type="fig"}B, day 1 no AMD3100) before cycling cells appeared ([Figure S1](#mmc1){ref-type="supplementary-material"}C). This was likely due to the recruitment of hematopoietic cells in early stages of regeneration ([@bib8], [@bib32]). To confirm this hypothesis, we applied 70% liver resection to a group of transgenic mice expressing the yellow fluorescent protein (YFP) from the Rosa26-LoxP-stop-LoxP-YFP allele in the hematopoietic cells (BM^YFP^) ([Figure 1](#fig1){ref-type="fig"}C). We found up to 30% of YFP+ cells in the liver, indicating a massive recruitment of hematopoietic cells within 24 hr from surgery ([Figures 1](#fig1){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}D).

Next, to determine the identity of the recruited YFP+ cells, we examined the expression of markers of mature circulating blood cells or bone-marrow-derived progenitors. YFP+ cells expressed HSPC (c-kit+/sca1+) and granulocyte monocyte progenitor (GMP) (c-Kit+/Sca1−/Cd34+/Cd16.32+) markers ([Figure S1](#mmc1){ref-type="supplementary-material"}E). In contrast, we excluded recruitment of cells from the peripheral blood because lineage-positive cells, such as B (B220+), T (Cd3+), and NK (CD49b+/CD3− and CD49b+/CD3+) cells, and macrophages (CD11b+ and CD11b+/F4-80+) did not increase into the resected liver after hepatectomy ([Figure S1](#mmc1){ref-type="supplementary-material"}F), suggesting that recruited YFP+ cells include mostly BMCs.

Therefore, we changed the rat model to account for both the role that BMC mobilization can play in liver regeneration in a mouse and the different timing of hepatocyte proliferation and regeneration. We included an explicit term for BMC recruitment, and added two time delays (τ and θ) between the Q and P states and the P and R states ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). We fitted the mathematical model to time-courses (7 day experiments) of wild-type mice that underwent hepatectomy; the dynamics of transition among the Q, P, and R states depend on BMC recruitment. The fitting accurately matches experimental proliferation and regeneration dynamics ([Figures 1](#fig1){ref-type="fig"}E and 1F).

BMC Mobilization Is Crucial for Hepatocyte Proliferation and Effective Regeneration {#sec2.2}
-----------------------------------------------------------------------------------

C-X-C motif chemokine receptor type 4 (CXCR4) and its ligand, SDF-1/CXCL12 (stromal cell-derived factor 1/C-X-C motif chemokine 12), are essential for the mobilization and migration of BMCs from the niche ([@bib6], [@bib22], [@bib29]). Thus, to investigate if the recruitment of BMCs into the liver was critical for its regeneration, we analyzed BMC recruitment after 70% resection in the CXCR4^fl/fl^/Vav-CRE/R26Y model, which carries BMCs deleted for CXCR4 and expressing YFP (BM^YFP/CXCR4−/−^) ([Figure 2](#fig2){ref-type="fig"}A). Of note, CXCR4^fl/fl^-Vav^CRE^ mice are normal and fertile and do not show apparent phenotypic defects, which could be ascribed to a bone marrow dysfunction. Indeed, it has been shown that Flt3-LSK cells in CXCR4^−/−^ mice are in a normal number as compared to wild-type mice and sustained long-term hematopoiesis ([@bib39]). Moreover, no major differences were found in the number of HSPCs in the fetal liver of CXCR4^−/−^ E14.5 embryos as compared to wild-type mice ([@bib16]).

As opposed to the BM^YFP^ wild-type mice, we observed a massive impairment of YFP+ BMC recruitment in BM^YFP/CXCR4−/−^ ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}A). Importantly, liver regeneration in BM^CXCR4−/−^ animals was severely compromised and, up to 30 days after resection, BM^CXCR4−/−^ mice could not entirely restore their liver mass ([Figure 2](#fig2){ref-type="fig"}C). Moreover, the block of liver mass regeneration was associated with an impairment of liver cell proliferation; the mitotic index and Ki67+ cells measured in liver sections were drastically reduced 3 days after hepatectomy in BM^CXCR4−/−^ mice ([Figures 2](#fig2){ref-type="fig"}D, 2E, [S2](#mmc1){ref-type="supplementary-material"}B, and S2C). Reduction of proliferation was confirmed by fluorescence-activated cell sorting (FACS) analysis, although it was recovered at late time points after the surgery, likely representing a compensatory effect through late liver parenchymal cell replication ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E).

Model fitting confirmed the crucial role for BMCs in triggering the proliferation and, consequently, the regeneration processes. When reproducing regeneration and proliferation dynamics in BM^CXCR4−/−^ mice ([Figures S2](#mmc1){ref-type="supplementary-material"}F and S2G), *k*~*Q*~ (the parameter governing the propensity of cells to become primed to proliferate) was decreased, whereas *k*~*req*~ and *k*~*R*~ (the parameters describing the return to the quiescent state), as well as the two delays (*τ* and θ), were increased as compared to their values in the control conditions ([Figure 2](#fig2){ref-type="fig"}F; [Table S1](#mmc2){ref-type="supplementary-material"}). Hence, by removing BMCs from the system, the transition of cells into a proliferative state is delayed and less effective, the transition from the primed to the replicating state is also delayed, and the sensitivity to requiescence signals is increased. Importantly, after simulating the model for a longer time (30 days), incomplete regeneration was observed in BM^CXCR4−/−^ mice ([Figure 2](#fig2){ref-type="fig"}G).

Given that a small fraction of BMC population persists in BM^CXCR4−/−^ mice ([Figure 2](#fig2){ref-type="fig"}B), the mathematical model was used to predict regeneration dynamics in the case of more severe reduction of BMCs. We found that the strength and timing of regeneration were further impaired compared to the actual experimental observations ([Figure 2](#fig2){ref-type="fig"}H).

Finally, we used the model to predict liver regeneration dynamics upon perturbation of BMC migration. Experimentally, it was not possible to assess for how long BMCs were recruited during the whole regeneration process. Thus, we ran simulations, stopping BMC recruitment 12 hr after resection. This resulted in a considerably impaired regeneration profile ([Figure 2](#fig2){ref-type="fig"}I), thereby suggesting that BMC recruitment should take place for at least 12 hr after surgery.

Upon Hepatectomy, Recruited BM Cells Fuse with Hepatocytes and the Hybrids Start to Proliferate Soon after Resection {#sec2.3}
--------------------------------------------------------------------------------------------------------------------

Cell fusion is a well-known developmental process and an essential mechanism of regeneration after an injury ([@bib27], [@bib33], [@bib43], [@bib42], [@bib48], [@bib2]). We therefore aimed to investigate whether mobilized BMCs could fuse with liver cells and promote regeneration after hepatectomy. We subjected 70% liver resection to a group of chimeric mice carrying the R26Y transgene, in which the BM was replaced with a double transgenic CAG-RFP/VAV-CRE BM from donor mice (R26Y-BM^RFP/CRE^) ([Figure 3](#fig3){ref-type="fig"}A). Vav-Cre is expressed only in the BM of transgenic mice ([@bib47]); furthermore, we excluded its expression in liver cells. We found a limited number of positive cells in sections, which likely corresponded to liver resident hematopoietic cells ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Hepatectomy was performed 6 weeks after BM repopulation when peripheral blood and bone marrow chimerisms were around 30% and 42%, respectively ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Up to 3 days after resection, we found that 10%--15% of recruited RFP+ cells in the liver were also YFP+, indicating fusion events. This percentage increased to ∼50% from 7 days up to 3 weeks after surgery, whereas recruited RFP+ cells decreased ([Figures 3](#fig3){ref-type="fig"}B, left plot, [3](#fig3){ref-type="fig"}C, and [S3](#mmc1){ref-type="supplementary-material"}C), suggesting an increase of hybrids and a decrease of BMCs in time in the resected liver. Importantly, we excluded major cell fusion events between BMCs and non-parenchymal liver cells ([Figures 3](#fig3){ref-type="fig"}B, right plot, and [S3](#mmc1){ref-type="supplementary-material"}D). As the control experiment, to exclude a possible leakiness of the R26Y transgene and therefore expression of YFP independently of Cre-mediated STOP codon excision, we transplanted R26Y mice with a BM^RFP^ (not expressing Cre). After hepatectomy, we observed neither YFP+/RFP+ nor YFP+/RFP− cells in R26Y-BM^RFP^ chimeric mice ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Furthermore, we also excluded formation of hybrids in the BM and peripheral blood of R26Y-BM^RFP/CRE^ ([Figure S3](#mmc1){ref-type="supplementary-material"}B).

The increase of the hybrids at different days after surgery was also evident by counting the number of YFP+ cells for each section at different days after resection ([Figure 3](#fig3){ref-type="fig"}D). These results were also confirmed by immunohistochemistry on sections ([Figure 3](#fig3){ref-type="fig"}E). Of note, we found several YFP+ binucleated cells (arrows in [Figure 3](#fig3){ref-type="fig"}D).

The majority of the hybrids (YFP+/RFP+ population) were positive for markers of HSPCs (c-kit+/sca-1+) 1 day after hepatectomy ([Figures 3](#fig3){ref-type="fig"}F and [S3](#mmc1){ref-type="supplementary-material"}E) and for the hepatocyte markers *Albumin*, hepatocyte nuclear factor 1 (*Hnf1*), and hepatocyte nuclear factor 4 alpha (HNF4α) from 1 day up to 21 days after surgery, indicating fusion of HSPCs with hepatocytes ([Figures 3](#fig3){ref-type="fig"}G and [S3](#mmc1){ref-type="supplementary-material"}F). We confirmed these results by performing HNF4α and c-kit immunostaining on YFP+/RFP+ hybrids sorted from the livers of R26Y-BM^RFP/CRE^ 24 hrs after surgery. We found cells that were positive for both HNF4α and c-Kit expression ([Figure 3](#fig3){ref-type="fig"}H). Furthermore, 24 hr after surgery, the hybrids expressed the cycling cell marker Ki67 and were polyploid ([Figures 3](#fig3){ref-type="fig"}I, [S3](#mmc1){ref-type="supplementary-material"}G, and S3H). In contrast, the unfused BMCs (RFP+/YFP−) and parenchymal liver cells (PCs) did not express Ki67 at this time point ([Figures 3](#fig3){ref-type="fig"}I, [S1](#mmc1){ref-type="supplementary-material"}C, and [S3](#mmc1){ref-type="supplementary-material"}G).

In order to further prove whether the hepatocytes were BMC fusion partners, we used the hepatocyte-specific *Albumin*-CRE chimeric mice ([@bib41]) carrying the R26Y bone marrow (Alb^CRE^-BM^R26Y^) ([Figure 4](#fig4){ref-type="fig"}A). The hybrids largely increased at different days after surgery ([Figures 4](#fig4){ref-type="fig"}B--4D), indicating fusion of BMCs with hepatocytes.

Finally, we observed that lineage-depleted bone marrow cells that are enriched for HSPCs could also fuse in vitro with PCs purified after liver hepatectomy, resulting in hybrids, which expressed HNF4α ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). In contrast, lineage-positive cells did not fuse efficiently in vitro and neither did their fusion capability increase after hepatectomy ([Figure S4](#mmc1){ref-type="supplementary-material"}A).

Overall, these results show that HSPCs can fuse with hepatocytes after liver resection and the hybrids have already entered the cell cycle 24 hr after the surgery, at a time when hepatocytes are still in the G0 resting phase of the cell cycle.

Because we showed that BMC migration in the liver of BM^CXCR4−/−^ animals after hepatectomy is impaired, we then aimed to investigate whether this block of BMC recruitment affects hybrid formation. Thus, we injected the CXCR4 antagonist AMD3100 ([@bib7]) into a group of chimeric R26Y-BM^RFP/CRE^ mice, which received 70% liver resection and were analyzed from 24 hr to 7 days after the surgery ([Figure 4](#fig4){ref-type="fig"}E). In the group of AMD3100-treated mice, migration of RFP+ BMCs ([Figure 4](#fig4){ref-type="fig"}F) and fusion of the recruited BMCs with the hepatocytes (YFP+ over RFP+ cells) were largely reduced after the hepatectomy ([Figures 4](#fig4){ref-type="fig"}G and [S4](#mmc1){ref-type="supplementary-material"}C). Interestingly, regeneration was largely impaired because liver mass corrected on body weight did not reach the level observed in the untreated mice ([Figure 1](#fig1){ref-type="fig"}B). Fitting the mathematical model on AMD3100-treated versus control mice, regeneration data confirmed impaired transition into the proliferative and replicating states, as in the comparison between BM^CXCR4−/−^ and BM^CXCR4fl/fl^ mice discussed above ([Figure S4](#mmc1){ref-type="supplementary-material"}D; [Table S1](#mmc2){ref-type="supplementary-material"}).

Of note, due to the lack of BMC recruitment in BM^YFP/CXCR4−/−^ mice and the reduced fusion after CXCR4 inhibition by AMD3100, polyploidy was accordingly impaired in BM^CXCR4−/−^ mice ([Figure S4](#mmc1){ref-type="supplementary-material"}E), indicating the major contribution of BMC recruitment and bone-marrow-derived hybrids to liver regeneration after hepatectomy.

Liver Regeneration Is Impaired upon Selective Ablation of Hybrids and the Mathematical Model Correctly Predicts this Phenotype {#sec2.4}
------------------------------------------------------------------------------------------------------------------------------

To definitively prove that the hybrids play an essential role to induce liver regeneration, we used a mouse model that allows ablation of the hybrids in the liver after surgery. We obtained chimeric mice carrying the Rosa26-LoxP-STOP-LoxP-DTR (R26-diphtheria toxin receptor) transgene, in whom the BM was replaced with the CAG-RFP/VAV-CRE BM from donor mice (R26DTR-BM^RFP/CRE^) ([@bib3]). Upon 70% liver resection, BM-derived hybrids expressed both RFP and DTR, making them sensitive to diphtheria toxin injection; thus, they were selectively ablated ([Figure 5](#fig5){ref-type="fig"}A). We found a substantial, although not complete, ablation of the hybrids (DTR+ over RFP+ cells) in the liver at the different days after surgery, which, as expected, paralleled the reduction of RFP+ liver cells ([Figures 4](#fig4){ref-type="fig"}B and 4C). Leakiness of the R26DTR promoter was excluded because neither DTR+/RFP+ nor DTR+/RFP− cells were found in R26DTR-BM^RFP^ mice (not expressing Cre) ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Importantly, we noticed a significant impairment of liver regeneration in the group of toxin-treated mice ([Figure 5](#fig5){ref-type="fig"}D). Accordingly, we found a severe reduction of the cell mitotic index, Ki67+ cell number, and polyploidy in toxin-treated mice ([Figures 5](#fig5){ref-type="fig"}E, 5F, and [S5](#mmc1){ref-type="supplementary-material"}B--S5F). As control, we excluded a possible toxic effect due to the toxin injection. This was tested in R26DTR mice and in R26DTR-BM^RFP^ mice, which both showed efficient liver regeneration after hepatectomy and toxin injection ([Figure S5](#mmc1){ref-type="supplementary-material"}G). Furthermore, proliferation in R26DTR-BM^RFP^ mice after resection and toxin injection was in the normal expected range ([Figure S5](#mmc1){ref-type="supplementary-material"}H).

Finally, we also generated chimeric Alb^Cre^-BM^R26DTR^ and analyzed liver regeneration 7 days after surgery in vehicle and toxin-injected mice. Regeneration was severely impaired when hepatocyte-derived hybrids were selectively ablated ([Figure 5](#fig5){ref-type="fig"}G).

Next, we fitted liver regeneration dynamics upon selective hybrid elimination. The fitted model confirmed major cell proliferation defects ([Figure 6](#fig6){ref-type="fig"}A) and liver regeneration impairment ([Figure 6](#fig6){ref-type="fig"}B). Identified parameters ([Table S1](#mmc2){ref-type="supplementary-material"}) indicate delayed and less efficient transitions of the cells both into the proliferative and replicating states ([Figure 2](#fig2){ref-type="fig"}F) as a consequence of the increased sensitivity to requiescence signals upon hybrid ablation. Moreover, no significant regeneration was observed in simulations of mice treated with toxin for up to 30 days ([Figure 6](#fig6){ref-type="fig"}C).

Of note, hybrids are included implicitly in the model rather than being modeled directly ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). To confirm our fitting results, we additionally derived an extended model, which explicitly accounts for the contribution of hybrids formed by BMCs and hepatocytes ([Figure S6](#mmc1){ref-type="supplementary-material"}A; see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for model derivation). Fitting the extended model on vehicle and toxin data ([Figures 6](#fig6){ref-type="fig"}D and 6E) confirmed the results obtained with the original model fitted on the same data-sets, i.e., alterations in the same parameters ([Figure 2](#fig2){ref-type="fig"}F; [Table S2](#mmc3){ref-type="supplementary-material"}). Similar results were obtained with fitting the extended model on BM^CXCR4fl/fl^ and BM^CXCR4−/−^ data described above ([Figures 6](#fig6){ref-type="fig"}F and 6G; [Table S2](#mmc3){ref-type="supplementary-material"}).

Recently, the existing formalism in [@bib18] has been extended to include hypertrophy ([@bib4]). Of note, the authors could reproduce experimental regeneration dynamics in a mouse (data from [@bib44]), but failed in matching proliferation dynamics. This suggests that the addition of hypertrophy alone is insufficient to fully recapitulate mouse liver regeneration upon hepatectomy. We investigated whether taking hypertrophy into account would change our modeling results. An extended model that also accounts for hypertrophy, in addition to delays and BMC recruitment ([Figure S6](#mmc1){ref-type="supplementary-material"}B; see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for model derivation), again confirmed the changes in parameters shown in [Figure 2](#fig2){ref-type="fig"}F when fitting BM^CXCR4fl/fl^ BM^CXCR4−/−^ data ([Figures 6](#fig6){ref-type="fig"}H and 6I; [Table S3](#mmc4){ref-type="supplementary-material"}) while improving the quality of fitting presented previously ([@bib4]).

In conclusion, it is possible to model hypertrophy or hybrids explicitly without affecting the main fitting results. Ablation of BMC-derived hybrids impairs proliferation of liver cells and, consequently, severely harms tissue regeneration after hepatectomy.

Mathematical Model Correctly Predicted Regeneration Dynamics and Proliferation upon 30% PHx {#sec2.5}
-------------------------------------------------------------------------------------------

Finally, we carried out experiments in which liver resection was applied for 30% of the mass of BM^CXCR4fl/fl^ and BM^CXCR4−/−^ and of toxin-treated or untreated R26DTR-BM^RFP/CRE^ mice. Data from the group of untreated R26DTR-BM^RFP/CRE^ mice were used to fit 30% hepatectomy ([Figure 7](#fig7){ref-type="fig"}A), and the model correctly predicted the regeneration dynamics of BM^CXCR4fl/fl^ mice upon 30% resection, matching experimental data ([Figure 7](#fig7){ref-type="fig"}B).

Interestingly, model simulations predicted the absence of proliferation and the synchronous dynamics of BMC recruitment and regeneration ([Figure 7](#fig7){ref-type="fig"}A). We validated these predictions. Indeed, also in agreement with previously published evidence ([@bib37]), the proliferation of hepatocytes was not seen ([Figures 7](#fig7){ref-type="fig"}C and 7D). Liver regeneration normally occurred in BM^CXCR4fl/fl^ and vehicle mice, whereas a full regeneration block was found in BM^CXCR4−/−^ and toxin-sensitive mice ([Figures 7](#fig7){ref-type="fig"}E and 7F). The latter groups also displayed a severe hybrid loss ([Figure 7](#fig7){ref-type="fig"}G). The model, however, could not reproduce the 30% hepatectomy in impaired mice because the removal of hybrids and BMC recruitment, in both the original and the extended models, result in impairment of the parameter values relative to proliferation, which is absent in these experiments.

Discussion {#sec3}
==========

In this study, we have demonstrated the essential role of BMCs for liver regeneration in mice. We found that recruitment of HSPCs in the liver, their fusion with hepatocytes, and subsequent proliferation of the hybrids before that of the hepatocytes is essential for regeneration after hepatectomy.

Previous studies have indicated the importance of the proliferation of hepatocytes for liver regeneration ([@bib12], [@bib15], [@bib35]). Alternatively, when hepatocyte replication is blocked, differentiation of ductal liver progenitor cells (oval cells) can play a crucial function ([@bib26]). Here, we introduced an additional layer of complexity to the picture, having identified the essential role of BM-derived hybrids in the regenerative process. Although we clearly showed that ablation of BM-derived hybrids significantly affects liver regeneration, it is still possible that ablation of an equivalent number of liver cells may affect the regeneration. This could be tested in the future by generating mice carrying tunable DTR, which will allow ablation of hepatocytes in a mosaic fashion.

We showed that regeneration is blocked when CXCL12-CXCR4 is impaired in the BMCs, which thereby cannot migrate in the resected liver and fuse with the hepatocytes upon hepatectomy. On the other hand, we cannot exclude that a minimal fraction of resident hybrids formed before the hepatectomy could contribute to the regeneration of the liver. However, this appears to be independent of a possible function of the CXCL12-CXCR4 axis. The CXCL12-CXCR4 axis maintains hematopoietic stem cell quiescence ([@bib39]), and it has been reported to increase proliferation of only hepatic oval cells ([@bib22]) or hepatic stem and cancer cells ([@bib20]). Importantly, in our experimental system, the deletion of the CXCL12-CXCR4 axis was restricted to the BMCs, leaving the hepatic compartment and its possible proliferation unaffected.

Besides, with hepatocytes, BMCs can fuse with a variety of somatic cells in vivo, such as gut cells, muscle cells, and neurons ([@bib33]). After BM-derived cell transplantation in damaged organs, the in-vivo-formed hybrids can regenerate the tissues, thereby providing a certain degree of functional recovery ([@bib10], [@bib27], [@bib43], [@bib42], [@bib2]). These observations indicate the importance of the hybrids in different regenerating tissue contexts.

The mammalian liver is highly polyploid. The ploidy increases with age, and it has been largely attributed to failed cytokinesis ([@bib11], [@bib34]). Polyploid hepatocytes are highly proliferative ([@bib45], [@bib53]) and can repopulate the host liver after transplantation in mice undergoing liver failure ([@bib13]). During regeneration, proliferating polyploid hepatocytes can also undergo multipolar mitosis and reduce their ploidy ([@bib13]). We observed binucleated and mononucleated cells, suggesting that heterokaryons might convert into synkaryons or reduce their ploidy during the regeneration process after the hepatectomy. Overall, liver function is fully maintained by polyploid cells and even by aneuploid hepatocytes ([@bib11]).

In addition to failed cytokinesis, polyploid cells are formed by fusion with BMCs, as previously reported ([@bib50], [@bib51]) and our data here show. In the fumarylacetoacetate hydrolase knockout mice (Fah^−/−^), hybrids formed upon fusion of BMCs with hepatocytes survived under selection pressure, i.e., upon withdrawal of the drug 2-(2-nitro-4-trifluoro-methylbenzyol)-1,3-cyclohexanedione (NTBC), which prevents liver disease in Fah^−/−^ mice ([@bib50], [@bib51]). Here, we observed formation of the hybrids without drug selection in a physiological model of liver regeneration, and discovered that they have a fundamental role for organ regeneration.

The function of this high ploidy was still not fully understood. Here, we demonstrated that proliferation of the hybrids before that of the hepatocytes is essential for liver mass regeneration after hepatectomy, clearly attributing a functional role to the polyploid cells. In addition, mathematical modeling showed that hybrid removal strongly impairs the regeneration process, delaying the transition of liver cells into a proliferative state and increasing the sensitivity to requiescence signals. Whether the newly formed hybrids directly trigger proliferation of the unfused hepatocytes, which enter in the cell cycle with a delay of 24 hr with respect to the hybrids, still needs to be defined.

We refined an existing mathematical model to account for the role of BMCs and hybrids in triggering regeneration, predicting regeneration efficiency in experimentally non-observable conditions. Our model explicitly considers BMCs while implicitly accounting for hybrids because BMCs are directly summed to the quiescent state ([Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). We opted for this approach because of limited experimental access to isolated hybrid dynamics in some of the mice used in this study (i.e., BM^CXCR4fl/fl^ and BM^CXCR4−/−^ animals). Nevertheless, extended formalisms, which include hybrids or that take into account hypertrophy as additional variables, confirmed results about the effect of impairment of BMC recruitment and hybrids on the system dynamics, confirming the power of our simplified approach.

Alternative mathematical formalisms describing liver physiology (reviewed in [@bib25]) account for multiscale levels of organization, extra-hepatic contribution ([@bib9]), and the different nature of cells participating in pathology or regeneration ([@bib24]). Our mathematical formalism has the potential to be extended to include spatial information and a more detailed description of the molecular processes involved in BM and hybrid-mediated regeneration; however, this would require the specification of additional parameters, which are at present not directly accessible experimentally. Although simple, our model has been parametrized by all available data and constitutes a first step in refining our quantitative understanding of regeneration and proliferation dynamics upon partial hepatectomy.

In humans, liver regeneration occurs after ischemia, toxic damage by alcohol, viral infection, or immune-mediated injury ([@bib30]). The liver regeneration mechanism should be fully dissected to elucidate how the liver responds to these types of insults and because partial resection is a current chirurgical practice for living liver donors. In contrast to rodents, the human liver regenerates more slowly, although efficiently for its function ([@bib49]). Thus, the length of cell proliferation can diversify the mechanisms of liver regeneration in mammals. The early proliferation of BM-derived hybrids we found here can be potentially exploited, not only to improve regeneration after hepatectomy, but also for future attempts toward regenerative therapy in patients affected by liver failure.

Experimental Procedures {#sec4}
=======================

Mice {#sec4.1}
----

All mice used in this study, R26Y \[B6.129X1-Gt(ROSA)26Sor^tm1(EYFP)Cos^/J\] ([@bib46]), BM^CXCR4fl/fl^ \[B6.129P2-Cxcr4^tm2Yzo^/J\] ([@bib14]), CAG-RFP \[B6.Cg-Tg(CAG-mRFP1)1F1 Hadj/J\] ([@bib21]), R26DTR \[C57BL/6-Gt(ROSA) 26Sortm1(HBEGF)Awai/J\] ([@bib3]), Vav-Cre ([@bib47]), and Alb-CRE \[B6.Cg-Tg(Alb-Cre)21Mgn/J\] ([@bib41]), were kept in a barrier and SPF animal facility in accordance with the CEEA (Ethical Committee for Animal Experimentation) of the Government of Catalonia. Males and females between 9 and 12 weeks were used for the experiments.

Flow Cytometry and Cell Sorting {#sec4.2}
-------------------------------

Mice were euthanized with CO~2~ and perfused with PBS until the liver lobes drained off the blood and appeared pale. Liver samples were collected, and cells were purified by a double disaggregation step, as described in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Purified cells were pelleted and resuspended in PBS with 2% FCS with DAPI and analyzed using a BD LSR Fortessa (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for more details). For cell sorting of in vitro and in vivo formed hybrids, samples were prepared as reported above and sorted using a BD FACS aria II.

Statistical Analysis {#sec4.3}
--------------------

The percentage of recruited BMCs, hybrids (in vivo and in vitro formed), and cycling cells (Ki67+) was measured by FACS and calculated using the BD FACSDiva software. For quantification of YFP+ hybrids (three random fields for each mouse) and Ki67+ hepatocytes (five random fields for each mouse) in liver sections, we used image processing tools in ImageJ software (US NIH; <http://rsb.info.nih.gov/ij>). Data are reported as mean ± SEM, and the number of replicates is specified in the figure legends. Differences were examined using two-tailed unpaired Student's t tests, and p \< 0.05 was considered significant.
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![Derivation of a Mathematical Model Accounting for BMC Recruitment in the Liver upon 70% Partial Hepatectomy\
(A) Schematic representation of cellular equations of the mathematical model. Blue font highlights the modifications to the rat model in [@bib18]. B, bone marrow cells; Q, P, and R, parameters as defined in the text and the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.\
(B) Liver regeneration of wild-type mice treated or not treated with AMD3100, which was calculated as liver weight/body weight ratio at different days after PHx.\
(C) Experimental scheme: recruitment of YFP+ cells into the liver of BM^YFP^ mice was analyzed by FACS 24 hr after PHx.\
(D) Percentage of recruited YFP+ cells with respect to living cells (mixed parenchymal and bone marrow cell fractions) 24 hr after PHx. See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for details about cell purification.\
(E and F) Simulations of the fitted model for liver mass regeneration (E) and proliferation (F) for wild-type mice (BM^CXCR4fl/fl^) using normalized data from [Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}D. Data are represented as mean ± SEM (n = 6, B and D). p \> 0.1; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.0001.\
See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc2){ref-type="supplementary-material"}.](gr1){#fig1}

![CXCR4 Deletion in the BM Affects Cell Proliferation and Liver Regeneration after 70% PHx\
(A) Experimental scheme: recruitment of YFP+ cells into the liver of BM^YFP^ and BM^YFP/CXCR4−/−^ mice was analyzed by FACS 24 hr after PHx.\
(B) Percentage of recruited YFP+ cells, which was calculated with respect to living cells (mixed parenchymal and bone marrow cell fractions) 24 hr after PHx in BM^YFP^ and BM^YFP/CXCR4−/−^ mice.\
(C) Liver regeneration of BM^CXCR4fl/fl^ and BM^CXCR4−/−^mice, which was calculated as liver weight/body weight ratio at different days after PHx.\
(D) Liver mitotic index of BM^CXCR4fl/fl^ and BM^CXCR4−/−^ mice following H&E staining at different days after PHx.\
(E) Quantification of Ki67+ liver cells by immunohistochemistry (IHC) in BM^CXCR4fl/fl^ and BM^CXCR4−/−^ mice at different days after PHx.\
(F) Scheme indicating, by red arrows, the variations of parameters fitting impaired mice data (i.e., BM^CXCR4−/−^, toxin-treated, and AMD3100) versus values for respective control mice.\
(G) 30-day simulated regeneration dynamics for BM^CXCR4fl/fl^ and BM^CXCR4−/−^ mice.\
(H) Predicted BM^CXCR4−/−^ regeneration and proliferation dynamics (solid lines) upon complete ablation of BMCs compared to the original fitting (dotted lines) and experimental data (dots, normalized data as in [Figures S2](#mmc1){ref-type="supplementary-material"}F and S2G ± SEM).\
(I) Prediction of regeneration dynamics (solid lines) when BMC recruitment is stopped after 12 hr in BM^CXCR4fl/fl^ mice against original fitting (dotted lines) and experimental data (dots, normalized data as in [Figures S2](#mmc1){ref-type="supplementary-material"}F and S2G ± SEM). Data are represented as mean ± SEM (n = 4, B and E; n = 5, D; n = 7, C). p \> 0.1; ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.0001.\
See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc2){ref-type="supplementary-material"}.](gr2){#fig2}

![BM-Recruited Cells Fuse with Parenchymal Cells after 70% PHx and the Hybrids Proliferate Soon After\
(A) Experimental scheme: cell fusion was analyzed at different days after PHx in chimeric R26Y-BM^RFP/CRE^ mice. Expression of the YFP occurs in the hybrids formed between BM^RFP/CRE^ and liver cells^R26Y^ after excision of the floxed stop codon by CRE. Hybrids will also be RFP+.\
(B) Percentage of YFP+ hybrids (PC-derived hybrids, left plot; NPC-derived hybrids, right plot), with respect to pre-gated RFP+ recruited BMCs at different days after PHx.\
(C) Percentage of recruited RFP+ BMCs, which was calculated with respect to living cells (mixed parenchymal and bone marrow cell fractions) 1, 3, 7, and 21 days after surgery.\
(D) Quantification of the YFP+ hybrids following immunofluorescence staining at different days after PHx in R26Y-BM^RFP/CRE^ mice. Inset: representative images; arrows indicate binucleated cells.\
(E) Representative IHC pictures of the YFP signal in sections of chimeric R26Y-BM^RFP/CRE^ mice at different days after PHx.\
(F) Percentage of c-kit+/sca-1+ cells, with respect to the total number of YFP+/RFP+ hybrids. Inset: representative FACS profile.\
(G) Percentage of FACS-sorted hybrids (RFP+/YFP+) expressing the hepatocyte-specific marker HNF4α 1 day and 21 days after PHx. Inset: representative FACS profiles.\
(H) HNF4α and c-Kit immunofluorescence on hybrids (RFP+/YFP+) sorted 24 hr after PHx in R26Y-BM^RFP/CRE^.\
(I) Percentage of Ki67+ hybrids (YFP+/RFP+) and BMCs (RFP+/YFP−) 24 hr after PHx in R26Y-BM^RFP/CRE^ mice. Data are represented as mean ± SEM (n = 3, B \[right plot\], F, G, and I; n = 4, B \[left plot\] and C; n = 6, D). p \> 0.1, ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.0001. Scale bar, 30 μm (D and E), 20 μm (H).\
See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![BMCs Fuse with Hepatocytes and a Block of BM Recruitment Significantly Affects Hybrid Formation\
(A) Experimental scheme: cell fusion was analyzed by FACS, immunofluorescence (IF), and IHC after hepatectomy in chimeric Alb^CRE^-BM^R26Y^ mice. Expression of the YFP occurs in the hybrids formed between BM^R26Y^ and hepatocytes^Alb/CRE^ after excision of the floxed stop codon by CRE.\
(B) Quantification of the YFP+ hybrids following immunofluorescence staining at different days after PHx in Alb^CRE^-BM^R26Y^mice. Inset: representative images.\
(C) Percentage of YFP+ hybrids, which was calculated with respect to living cells (mixed parenchymal and bone marrow cell fractions) 24 hr after surgery.\
(D) Representative IHC pictures of the YFP signal in sections of chimeric Alb^CRE^-BM^R26Y^ mice at different days after PHx.\
(E) Experimental scheme: cell fusion and liver mass regeneration was analyzed at different days after hepatectomy in chimeric R26Y-BM^RFP/CRE^ mice upon CXCR4 inhibition by the antagonist AMD3100.\
(F) Percentage of recruited RFP+ BMCs over living cells (mixed parenchymal and bone marrow cell fractions), which was measured 1, 3, and 7 days after surgery in the presence or without the presence of the CXCR4 antagonist AMD3100.\
(G) Percentage of YFP+ hybrids, with respect to pre-gated RFP+ recruited BMCs at different days after PHx in the presence or without the presence of the CXCR4 antagonist AMD3100. Data are represented as mean ± SEM (n = 3, F and G; n = 4, C; n = 6, B). p \> 0.1; ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.0001. Scale bar, 30 μm (B and D).\
See also [Figure S4](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Selective Ablation of In Vivo Formed Hybrids Reduces Cell Proliferation and Impairs Liver Regeneration\
(A) Experimental scheme: cell fusion and liver mass regeneration was analyzed at different days after PHx in chimeric R26DTR-BM^RFP/CRE^ mice. Expression of the diphtheria toxin receptor (DTR) occurs in the hybrids formed between BM^RFP/CRE^ and liver cells^R26DTR^ after excision of the floxed stop codon by CRE. Hybrids will be RFP+/DTR+ and therefore sensitive to diphtheria toxin injection.\
(B) Percentage of DTR+ hybrids, with respect to RFP+ recruited BMCs at different days after PHx.\
(C) Percentage of recruited RFP+ BMCs over living cells (mixed parenchymal and bone marrow cell fractions), which was measured 1, 3, and 7 days after 70% PHx of R26DTR-BM^RFP/CRE^ mice injected or not injected with diphtheria toxin.\
(D) Liver regeneration of R26DTR-BM^RFP/CRE^ mice treated or not treated with diphtheria toxin, which was calculated as liver weight/body weight at different days after PHx.\
(E) Liver mitotic index of R26DTR-BM^RFP/CRE^ mice treated or not treated with diphtheria toxin following H&E staining at different days after PHx.\
(F) Quantification of Ki67+ liver cells by IHC in mice injected or not treated with diphtheria toxin at different days after PHx.\
(G) Liver regeneration of R26DTR-BM^Alb/CRE^ mice treated or not treated with diphtheria toxin, which was calculated as liver weight/body weight ratio 7 days after 70% PHx.\
Circles indicate toxin- and vehicle- treated mice. Data are represented as mean ± SEM (n = 3, B and C; n = 4, E, F, and G; n = 5, D). p \> 0.1; ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.0001.\
See also [Figure S5](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

![Modeling the Contribution of BMC Recruitment and Cell Fusion to Cell Proliferation and Liver Regeneration Dynamics\
(A and B) Simulations of the fitted model for proliferation (A) and liver mass (B) for R26DTR-BM^RFP/CRE^ in toxin and vehicle-treated mice using normalized data from [Figures 5](#fig5){ref-type="fig"}D and [S5](#mmc1){ref-type="supplementary-material"}D.\
(C) 30-day simulated regeneration dynamics for R26DTR-BM^RFP/CRE^ in toxin and vehicle-treated mice.\
(D and E) Simulations of the fitted extended model (hybrids) for proliferation (D) and liver mass (E) for R26DTR-BM^RFP/CRE^ toxin and vehicle-treated mice using normalized data from [Figures 5](#fig5){ref-type="fig"}D and [S5](#mmc1){ref-type="supplementary-material"}D.\
(F and G) Simulations of the fitted extended model (hybrids) for proliferation (F) and liver mass (G) for BM^CXCR4fl/fl^ and BM^CXCR4−/−^ mice using normalized data from [Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}D.\
(H and I) Simulations of the fitted extended model (hypertrophy) for liver mass (H) and proliferation (I) for BM^CXCR4fl/fl^ and BM^CXCR4−/−^ mice using normalized data from [Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}D. See also [Figure S6](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc2){ref-type="supplementary-material"}, [S2](#mmc3){ref-type="supplementary-material"}, and [S3](#mmc4){ref-type="supplementary-material"}.](gr6){#fig6}

![Modeling Simulations and Experimental Validations for the 30% PHx Model\
(A) Fitted model simulations (solid lines) and experimental data (dots, normalized data from [Figure 7](#fig7){ref-type="fig"}F ± SEM) for regeneration, BMC recruitment, and proliferation dynamics upon 30% PHx in vehicle-treated mice.\
(B) Prediction of regeneration dynamics (solid lines) for 30% PHx in BM^CXCR4fl/fl^ mice against experimental data (dots, normalized data from [Figure 7](#fig7){ref-type="fig"}E ± SEM).\
(C) Percentage of Ki67+ cells over parenchymal cells, which was measured by FACS 1, 2, 3, and 4 days after 30% PHx in BM^CXCR4fl/fl^ and BM^CXCR4^.\
(D) Percentage of Ki67+ cells over parenchymal cells, which was measured by FACS 1, 2, 3, and 4 days after 30% PHx in R26DTR-BM^RFP/CRE^ chimeric mice treated or not treated with diphtheria toxin.\
(E) Liver regeneration of BM^CXCR4fl/fl^ and BM^CXCR4−/−^ mice, which was calculated as liver weight/body weight ratio 1, 2, 3, and 4 days after 30% PHx.\
(F) Liver regeneration of R26DTR-BM^RFP/CRE^ chimeric mice treated or not treated with diphtheria toxin, which was calculated as liver weight/body weight ratio 1, 2, 3, and 4 days after 30% PHx.\
(G) Percentage of in vivo formed hybrids between recruited BM^RFP/CRE^ and parenchymal liver cells^R26DTR^ 1, 2, 3, and 4 days after 30% PHx in control mice and mice injected with diphtheria toxin. The percentage of hybrids (DTR+/RFP+) was calculated with respect to living cells (mixed parenchymal and bone marrow cell fractions). Data are represented as mean ± SEM (n = 3, C, D, F, and G; n = 5, E). p \> 0.1, ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.0001.\
See also [Table S1](#mmc2){ref-type="supplementary-material"}.](gr7){#fig7}
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